Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Britton

Showing results (351-360 of 359) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 359 results.
Journal of Medicinal Chemistry|November 26, 1997
Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonistsP A Hipskind, K L Lobb, J A Nixon, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Frontiers in Cell and Developmental Biology|March 7, 2025
Evidence for Fgf and Wnt regulation of <i>Lhx2</i> during limb development via two limb-specific <i>Lhx2</i>-associated <i>cis</i>-regulatory modulesJessica C Britton, Anett Somogyi-Leatigaga, Billy A Watson, et al.
Journal of Psychopharmacology (Oxford, England)|September 4, 2010
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersS J Wilson, D J Nutt, C Alford, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 12, 2025
Regional diagnostic reference levels in paediatric interventional cardiology in Latin America and the Caribbean countriesC Ubeda, E Vano, M D Perez, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulatorJunliang Hao, Veronique Dehlinger, Adam M Fivush, et al.
Nature Genetics|June 5, 2023
Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse modelKatherine A Waugh, Ross Minter, Jessica Baxter, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like ActivityMark D Chappell, Renhua Li, Stephon C Smith, et al.
Journal of Neurochemistry|January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainH F Dovey, V John, J P Anderson, et al.
Pageof 36

Showing results (351-360 of 359) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 359 results.
Journal of Medicinal Chemistry|November 26, 1997
Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonistsP A Hipskind, K L Lobb, J A Nixon, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Frontiers in Cell and Developmental Biology|March 7, 2025
Evidence for Fgf and Wnt regulation of <i>Lhx2</i> during limb development via two limb-specific <i>Lhx2</i>-associated <i>cis</i>-regulatory modulesJessica C Britton, Anett Somogyi-Leatigaga, Billy A Watson, et al.
Journal of Psychopharmacology (Oxford, England)|September 4, 2010
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersS J Wilson, D J Nutt, C Alford, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 12, 2025
Regional diagnostic reference levels in paediatric interventional cardiology in Latin America and the Caribbean countriesC Ubeda, E Vano, M D Perez, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulatorJunliang Hao, Veronique Dehlinger, Adam M Fivush, et al.
Nature Genetics|June 5, 2023
Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse modelKatherine A Waugh, Ross Minter, Jessica Baxter, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like ActivityMark D Chappell, Renhua Li, Stephon C Smith, et al.
Journal of Neurochemistry|January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainH F Dovey, V John, J P Anderson, et al.
Pageof 36